APGE · US market
Apogee Therapeutics Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$10.19bnFinancials dated 30 June 2026Price dated 2 September 2026
Core valuation
Calculation inputs
- Trailing earnings
- -US$294.37m
- Latest-quarter run-rate earnings
- -US$343.42m
- Latest fiscal-year earnings
- -US$255.84m
- Trailing revenue
- US$0.00
- Latest-quarter run-rate revenue
- US$0.00
- Latest fiscal-year revenue
- Unavailable
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- GDOC · Goldman Sachs Future Health Care Equity ETF1.97% weight · Holdings dated 31 May 2026
- XBI · State Street SPDR S&P Biotech ETF1.47% weight · Holdings dated 21 August 2026
- GURU · Global X Guru Index ETF1.29% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- TCAF · T. Rowe Price Capital Appreciation Equity ETF1.17% weight · Holdings dated 30 June 2026
- IHSAX · The Hartford Small Company Fund Class A0.86% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- TMED · T. Rowe Price Health Care ETF0.75% weight · Holdings dated 30 June 2026
- QUAZX · AB Small Cap Growth Portfolio Class Z0.72% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- CHCLX · AB Discovery Growth Fund Class A0.67% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- SGRW · Harbor Active Small Cap Growth ETF0.66% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
- GSBDX · Goldman Sachs Small Cap Growth Fund Class A Shares0.64% weight · Holdings dated 31 May 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 30 June 2026. Informational research, not investment advice.